Skip to content

A Two-Phase Clinical Study Evaluating the Efficacy and Safety of SCD-2101 in Treating Functional Constipation With Yang-Deficiency Pattern

A Two-Phase Clinical Study Evaluating the Efficacy and Safety of SCD-2101 in Treating Functional Constipation With Yang-Deficiency Pattern

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000728
Enrollment
Unknown
Registered
2026-03-25
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation With Yang-Deficiency Pattern

Interventions

Low-Dose group:Low-Dose SCD-2101 15g/day
Medium-Dose group:Medium-Dose SCD-2101 22.5g/day
High-Dose group:Medium-Dose SCD-2101 30g/day
SCD-2101 group:Final dose to be selected based on Phase 1 results, twice daily for 8 weeks
Placebo group:Matching SCD-2101,twice daily for 8 weeks

Sponsors

Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1 Adults at least 18 years 2 Meet Rome IV criteria for functional constipation 3 Meet TCM 2017 Consensus criteria for Yang-deficiency constipation 4 CSBM at most 2 per week based on 2 weeks diary 5 Able to understand written or spoken Chinese instructions 6 Able to complete diaries independently 7 Provided written informed consent

Exclusion criteria

Exclusion criteria: Subjects meeting any of the following criteria will be excluded: (1) Secondary constipation (constipation caused by medication or other diseases). (2) Currently using or requiring continued use of medications that may affect study outcomes (including but not limited to: antibiotics, hormonal drugs, analgesics, neurotransmitter-related drugs, intestinal flora modulators, etc.). (3) Clinically significant and untreated abnormalities detected by colonoscopy or sigmoidoscopy (applicable if any of the following conditions are met: (1) age 50 years or older; (2) family history of colorectal cancer or familial polyposis; (3) presence of alarm symptoms within the last 6 months (any of the following: unexplained weight loss of =10% within 3 months; hematochezia (not caused by hemorrhoids or anal fissures); unexplained fever; anemia)). (4) Allergy to any Chinese herbal medicine included in the study (Cistanche deserticola, Senna leaves, Astragalus membranaceus, Magnolia officinalis). (5) Clinically significant abnormalities in laboratory tests or imaging studies within the last 6 months. (6) History of abdominal surgery within the past year (except laparoscopic appendectomy). (7) Pregnant or breastfeeding women, or women planning to become pregnant within the next six months. (8) Individuals with psychiatric disorders or those requiring psychotropic medications. (9) Judged by the investigator as unsuitable for participation in the study due to psychological or physical reasons.

Design outcomes

Primary

MeasureTime frame
Overall CSBM Responder Rate;

Secondary

MeasureTime frame
Weekly CSBM responder rate;Change from Baseline in the Mean Weekly Frequency of Complete Spontaneous Bowel Movements (CSBMs);Title: Change from Baseline in the Mean Weekly Frequency of Spontaneous Bowel Movements (SBMs);Mean weekly stool consistency (Bristol Stool Form Scale);Change from Baseline in the Weekly Use Frequency of Rescue Medication;Change from Baseline in the PAC-SYM Questionnaire Score;Change from Baseline in the PAC-QoL Questionnaire Score;Change from Baseline in the TCM Pattern Score (Yang-deficiency constipation score);Lifestyle and Dietary Habits Questionnaire;

Countries

China

Contacts

Public ContactZhong Wenying

Department of Gastroenterology,Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine(Nanhai District Hospital of Traditional Chinese Medicine of Foshan City

LIANGKANGLI@LIVE.COM+86 13660374507

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026